FDA Inspection 1251796 - Molecular Imaging Program at Stanford - October 04, 2024

Record Details

This FDA Inspection record concerns Molecular Imaging Program at Stanford, with an inspection on October 4, 2024, issued by the San Francisco District Office, covering human drugs.

Company: Molecular Imaging Program at Stanford
Inspection Date: October 4, 2024
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · e0ae1dd2-0ff8-4ed5-a693-61719b1f26f6

Violation Codes3

21 CFR 1121 CFR 212.20(e)21 CFR 212.60(d)

Full citation text and observation details available on the Dashboard.